1,2,3,4-Tetrahydroacridin-9-amine hydrochloride, 98.0%, 1g

5-Acetyluracil>98.0%(HPLC)(T)1g

4-(Phenylazo)diphenylamine>98.0%(T)5g

5-CHLORO-1H-INDAZOL-3-YLAMINE, 95%, 5g

Recipiente de evaporación ROTILABO® forma alta, 250 ml, 1 Pieza

2-(4-NITROPHENYL)-1H-BENZOIMIDAZOLE, 97.0%, 250mg

methyl (5S,8S,10aR)-5-(tert-butoxycarbonylamino)-6-oxo-2,3,4,5,8,9,10,10a-octahydro-1H-pyrrolo[1,2-a][1,5]diazocine-8-carboxylate, 97, 5g

1-PIPERIDINECARBOXYLIC ACID, 3-(FLUOROMETHYL)-, 1,1-DIMETHYLETHYL ESTER, 95.0%, 1g

1-Pyridin-4-yl-ethylamine acid, tech, 250mg

2-Ethoxy-1-naphthaldehyde>98.0%(GC)5g

Losartan>98.0%(HPLC)(T)5g

3,4,5-Trichloro-benzoic acid, 95.0%, 5g

2-(1-pyrrolidinylmethyl)-1,3-thiazole-5-carboxylic acid hydrochloride hydrate, 95.0%, 1g